Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

ERLOCIP erlotinib (as hydrochloride) 100 mg tablet blister pack (337801)

ARTG ID

337801

ARTG Name

ERLOCIP erlotinib (as hydrochloride) 100 mg tablet blister pack

Sponsor

Cipla Australia Pty Ltd

ARTG Date

April 30, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Cipla Australia Pty Ltd

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/63ffb9fe46258b8b529046103c5384f0.pdf

Active Ingredients

Ingredient Name

erlotinib hydrochloride

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

ERLOCIP erlotinib (as hydrochloride) 100 mg tablet blister pack (337801) - TGA 批准文号 | MedPath